Publicacións (142) Publicacións de Manuel Vicente Sánchez Chapado

2023

  1. Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

2022

  1. A Highly Sensitive Immunoassay for Determination of Immune Response to SARS-CoV-2 in Capillary Blood Samples

    Biomedicines, Vol. 10, Núm. 11

2021

  1. Homeostasis: apoptosis and cell cycle in normal and pathological prostate

    Aging Male, Vol. 23, Núm. 5, pp. 335-345

  2. Increase in ischemia-modified albumin and pregnancy-associated plasma protein-a in covid-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 23

2020

  1. Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success

    World Journal of Urology, Vol. 38, Núm. 12, pp. 3121-3129

2018

  1. Does [-2]Pro-Prostate Specific Antigen Meet the Criteria to Justify Its Inclusion in the Clinical Decision-Making Process?

    Urologia Internationalis, Vol. 100, Núm. 2, pp. 146-154

  2. PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer

    Aging Male, Vol. 21, Núm. 3, pp. 211-222

  3. Validación del índice de salud prostática en un modelo predictivo de cáncer de próstata

    Actas Urologicas Espanolas, Vol. 42, Núm. 1, pp. 25-32

2017

  1. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer

    APMIS, Vol. 125, Núm. 9, pp. 787-796

  2. Does obesity modify prostate cancer detection in a European cohort?

    Central European Journal of Urology, Vol. 70, Núm. 1, pp. 30-36

2016

  1. A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy

    Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25

  2. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer

    Oncotarget, Vol. 7, Núm. 32, pp. 52195-52206

  3. Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile

    Journal of Urology, Vol. 195, Núm. 3, pp. 619-626

  4. Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

    European Journal of Surgical Oncology, Vol. 42, Núm. 5, pp. 744-750

  5. Survival predictors in patients with prostate adenocarcinoma with hormonal blockade

    Pathology Research and Practice, Vol. 212, Núm. 10, pp. 899-903

2015

  1. Asociación entre síndrome metabólico y cáncer de próstata: Efecto sobre su agresividad y progresión

    Actas Urologicas Espanolas, Vol. 39, Núm. 3, pp. 154-160

  2. Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?

    European Urology, Vol. 67, Núm. 5, pp. 943-951

  3. Evolución de las características del paciente candidato a prostatectomía radical y de los resultados obtenidos con la técnica

    Actas Urologicas Espanolas, Vol. 39, Núm. 2, pp. 78-84

  4. VIP induces NF-κB1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells

    Cellular Signalling, Vol. 27, Núm. 2, pp. 236-244

2014

  1. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis

    Prostate, Vol. 74, Núm. 12, pp. 1171-1182